Related Experiment Video

Updated: Aug 16, 2026

Assaying Protein Kinase Activity with Radiolabeled ATP
08:05

Assaying Protein Kinase Activity with Radiolabeled ATP

Published on: May 26, 2017

pp32/ I-1(PP2A) negatively regulates the Raf-1/MEK/ERK pathway

Chikako Fukukawa1, Nobuhiro Tanuma, Tadashi Okada

  • 1Division of Biochemical Oncology and Immunology, Institute for Genetic Medicine, Hokkaido University, Kita-15, Nishi-7, Kita-ku, Sapporo 060-0815, Japan.

Cancer Letters
|July 26, 2005
PubMed

Insights

The protein pp32 (phosphatase 2A inhibitor 1) suppresses the Raf-MEK-ERK pathway, a key signaling cascade. This interaction suggests pp32 plays a role in tumor suppression by regulating cell growth signals.

Area of Science:

  • Molecular Biology
  • Cell Signaling
  • Cancer Research

Background:

  • The Raf-MEK-ERK signaling pathway is crucial for cell proliferation and survival.
  • Dysregulation of this pathway is implicated in various cancers.
  • The role of pp32 (also known as I-1PP2A) in this pathway is not fully understood.

Purpose of the Study:

  • To investigate the interaction between pp32 and the Raf-MEK-ERK signaling pathway.
  • To determine how pp32 influences the activation of Raf-1, MEK, and ERK.
  • To elucidate the potential role of pp32 in tumor suppression via this pathway.

Main Methods:

  • Overexpression of pp32 in cellular models.
  • Knockdown of pp32 using small interfering RNA (siRNA).
  • Western blot analysis to assess protein levels and activation states of Raf-1, MEK, and ERK.

Main Results:

  • Overexpression of pp32 inhibited Raf-1 activation, leading to decreased ERK activation.
  • The C-terminal region of pp32 was identified as essential for suppressing Raf-1.
  • pp32 knockdown using siRNA resulted in enhanced activation of both ERK and MEK.

Conclusions:

  • pp32 negatively regulates the Raf-MEK-ERK signaling pathway.
  • Tumor suppression by pp32 is, at least partly, mediated through the downregulation of this pathway.
  • pp32 represents a potential therapeutic target for cancers driven by aberrant Raf-MEK-ERK signaling.

More Related Videos

Methods to Study Mrp4-containing Macromolecular Complexes in the Regulation of Fibroblast Migration10:43

Methods to Study Mrp4-containing Macromolecular Complexes in the Regulation of Fibroblast Migration

Published on: May 19, 2016

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...